FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4492611000001106: Bextra 40mg tablets (Pfizer Ltd) 5 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26534101000001118 Bextra 40mg tablets (Pfizer Ltd) 5 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26534201000001113 Bextra 40mg tablets (Pfizer Ltd) 5 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Is a Valdecoxib 40mg tablets 5 tablet true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Is pack of Bextra 40mg tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has active ingredient Valdecoxib false Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has AMP Bextra 40mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has specific active ingredient Valdecoxib true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bextra 40mg tablets (Pfizer Ltd) 5 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start